GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » 3-Year Dividend Growth Rate

Hangzhou Tigermed Consulting Co (SZSE:300347) 3-Year Dividend Growth Rate : 25.50% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co 3-Year Dividend Growth Rate?

Hangzhou Tigermed Consulting Co's Dividends per Share for the three months ended in Dec. 2023 was ¥0.00.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate or its related term are showing as below:

SZSE:300347' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -20.4   Med: 30.05   Max: 60.7
Current: 25.5

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hangzhou Tigermed Consulting Co was 60.70% per year. The lowest was -20.40% per year. And the median was 30.05% per year.

SZSE:300347's 3-Year Dividend Growth Rate is ranked better than
65% of 40 companies
in the Medical Diagnostics & Research industry
Industry Median: 9.25 vs SZSE:300347: 25.50

During the past 12 months, Hangzhou Tigermed Consulting Co's average Dividends Per Share Growth Rate was 10.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 25.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 31.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 22.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00. As of today, Hangzhou Tigermed Consulting Co's Dividend Yield % is 0.95%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's 3-Year Dividend Growth Rate falls into.



Hangzhou Tigermed Consulting Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Hangzhou Tigermed Consulting Co  (SZSE:300347) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hangzhou Tigermed Consulting Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 0.479
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Hangzhou Tigermed Consulting Co was 0.64. The lowest was 0.21. And the median was 0.31.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Hangzhou Tigermed Consulting Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.5502023-07-072023-07-062023-07-07Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Hangzhou Tigermed Consulting Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.55/57.70
=0.95 %

Current Share Price is ¥57.70.
Hangzhou Tigermed Consulting Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.55.

During the past 13 years, the highest Dividend Yield of Hangzhou Tigermed Consulting Co was 1.43%. The lowest was 0.14%. And the median was 0.43%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co 3-Year Dividend Growth Rate Related Terms>


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines